GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: 3',4'-dideoxykanamycin B | debecacin
                                 
                                                         
                            
                            
                            
                                 
                                
                                dibekacin is an approved drug 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Dibekacin is a semisynthetic derivative of bekanamycin (kanamycin B), with activity against Gram-positive and Gram-negative bacteria [1]. It belongs to the aminoglycoside class of antibacterial compounds.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| MIC for in vitro antibacterial activity against Staphylococcus aureus FDA 209P (0.78 μg/ml) and Escherichia coli (1.56 μg/ml) is similar to bekanamycin [1]. The same study found that dibekacin demonstrates activity against E. coli strains carrying the R factor (1.56-3.12 μg/ml) and against Pseudomonas aeruginosa (0.78-6.25 μg/ml), for which bekanamycin shows no activity. |